Coding variants in RPL3L and MYZAP increase risk of atrial fibrillation.
Communications Biology
Thorolfsdottir, Rosa B RB; Sveinbjornsson, Gardar G; Sulem, Patrick P; Nielsen, Jonas B JB; Jonsson, Stefan S; Halldorsson, Gisli H GH; Melsted, Pall P; Ivarsdottir, Erna V EV; Davidsson, Olafur B OB; Kristjansson, Ragnar P RP; Thorleifsson, Gudmar G; Helgadottir, Anna A; Gretarsdottir, Solveig S; Norddahl, Gudmundur G; Rajamani, Sridharan S; Torfason, Bjarni B; Valgardsson, Atli S AS; Sverrisson, Jon T JT; Tragante, Vinicius V; Holmen, Oddgeir L OL; Asselbergs, Folkert W FW; Roden, Dan M DM; Darbar, Dawood D; Pedersen, Terje R TR; Sabatine, Marc S MS; Willer, Cristen J CJ; Løchen, Maja-Lisa ML; Halldorsson, Bjarni V BV; Jonsdottir, Ingileif I; Hveem, Kristian K; Arnar, David O DO; Thorsteinsdottir, Unnur U; Gudbjartsson, Daniel F DF; Holm, Hilma H; Stefansson, Kari K
Publication Date: 2018
Variant appearance in text: RPL3L: Val360Met; rs140116056
NCI-60 whole exome sequencing and pharmacological CellMiner analyses.
Plos One
Reinhold, William C WC; Varma, Sudhir S; Sousa, Fabricio F; Sunshine, Margot M; Abaan, Ogan D OD; Davis, Sean R SR; Reinhold, Spencer W SW; Kohn, Kurt W KW; Morris, Joel J; Meltzer, Paul S PS; Doroshow, James H JH; Pommier, Yves Y
Publication Date: 2014
Variant appearance in text: RPL3L: V360M; rs140116056